One Nucleus’ On Helix Conference 2023, provided insight into the current climate for Biotech companies, including the international outlook, and what to expect in the future. The past few years have been tough for the international Biotech market, with funding, Brexit, new regulations, trade agreements and supply chain issues. Additionally, valuations have fallen and consequently […]
YOUNG biotech companies need “patient investors” with “deep pockets” to weather today’s financial storms, the head of Novo Holdings Seed Investments has told the Optimum Perspectives podcast. In an in-depth interview, Søren Møller said fledgling firms should accept it might be some time before investor confidence returns to the sector – and they need to […]
LET’S play a word association game. AI. Healthcare. Are you thinking what I’m thinking? If so, you‘re thinking about drug discovery. It is a very hot topic in pharma right now. Billions are being poured into efforts to use artificial intelligence (AI) to spot new drugs. And for good reason. ‘Traditional’ drug discovery methods are […]
As the NHS continues to tackle understaffing and over-demand on its hospital capacity, the potential for doctors to support certain patients at home via a ‘virtual wards’ service has become a hot topic in the media and beyond. The Government’s commitment to making an initial £200m available to virtual wards in 2022-23 and a further […]
London, UK, 15 May 2023 – Optimum Strategic Communications (“Optimum”), the specialist life sciences communications consultancy, today announces the appointment of highly-experienced medical journalist, Stephen Adams, as a full-time member of its team. Stephen, who joins as an Associate Director with immediate effect, spent 10 years at The Mail on Sunday, first as Health Correspondent […]
